Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with endstage renal disease on haemodialysis or GFR <30 mL/min | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with endstage renal disease on haemodialysis or GFR <30 mL/min

Nazario HE, Ndungu M, Modi AA. Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with endstage renal disease on haemodialysis or GFR <30 mL/min. Liver Int. 2015 Dec 15.th ed. 2016;36(6):798-801.

Publication Type:

Journal Article

Authors:

Nazario, HE.; Ndungu, M.; Modi, AA.

Source:

Liver Int, Volume 36, Issue 6, p.798-801 (2016)

Cited On:

Patients with Renal Impairment

Export Citation:

RIS Format

Top